Back to dashboard
CommercialAdministrativeLow impact

Viberzi (eluxadoline)

Blue Cross & Blue Shield of Mississippi·MS · Gastroenterology, Family Medicine, Internal Medicine·Medical Policy
Effective date
Oct 1, 2024
We identified it
Jun 20, 2026
Days to comply
—

Summary

BCBS Mississippi updated their Viberzi (eluxadoline) policy with revised language changing 'member' to 'individual' throughout the document. The policy requirements for prior authorization, coverage criteria, and contraindications remain unchanged from the previous version.

Action Required

Action needed
No immediate action required. This is a terminology update only - all prior authorization requirements, coverage criteria, and billing procedures for Viberzi (eluxadoline) remain the same. Continue following existing prior auth processes for IBS-D patients requesting this medication.

Related policy hubs